Identification of potential biomarkers of genotoxicity and carcinogenicity in L5178Y mouse lymphoma cells by cDNA microarray analysis

In the present study, cDNA microarray analyses were performed with mouse cDNA chips in order to evaluate similarities and differences in the gene expression profiles for compounds differing in their genotoxic and carcinogenic potential. Eight test substances were evaluated, two each from four classes of compounds: genotoxic carcinogens (1,2‐dibromoethane and glycidol), genotoxic noncarcinogens (8‐hydroxyquinoline and emodin), nongenotoxic carcinogens (methyl carbamate and o‐nitrotoluene), and nongenotoxic noncarcinogens (D‐mannitol and 1,2‐dichlorobenzene). Quadruplicate hybridization experiments were performed in order to identify a set of genes with significant expression changes for these four classes of substances. Twelve genes were consistently altered more than twofold by the genotoxic noncarcinogens while four genes were consistently regulated by the nongenotoxic carcinogens. One gene (Trp63) was identified whose expression was upregulated by all four genotoxic substances regardless of the presence or absence of carcinogenicity; this finding, however, was not confirmed by quantitative real‐time RT‐PCR. RT‐PCR did confirm the change in expression of 9 of 15 genes (60%) identified by microarray analysis. Interestingly, the downregulated genes were least likely to be validated by real‐time RT‐PCR. Those genes showing more than a twofold change in expression level in response to at least one substance were further analyzed with hierarchical clustering after category assignment of each gene according to its main cellular function. Clustering revealed differences in the gene expression profiles between the genotoxic and nongenotoxic substances for genes involved in cell cycle control, the stress response, and the immune response. However, no clustering specific to all four carcinogenic substances was observed in any of the functional categories. Taken together, these results suggest that gene expression profiling in mouse lymphoma cells can provide valuable information for the evaluation of potential genotoxicity but may have limitations in predicting carcinogenicity. Environ. Mol. Mutagen., 2005. © 2004 Wiley‐Liss, Inc.

[1]  D. Clive,et al.  Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system. , 1979, Mutation research.

[2]  M. Chung,et al.  Enhanced prediction of potential rodent carcinogenicity by utilizing comet assay and apoptotic assay in combination. , 2003, Mutation research.

[3]  Chang-Woo Song,et al.  cDNA microarray gene expression profiling of hydroxyurea, paclitaxel, and p‐anisidine, genotoxic compounds with differing tumorigenicity results , 2003, Environmental and molecular mutagenesis.

[4]  K. B. Pedersen,et al.  Nuclear localization of the metastasis‐related protein S100A4 correlates with tumour stage in colorectal cancer , 2003, The Journal of pathology.

[5]  H. Stopper,et al.  Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: topoisomerase II mediated? , 1996, Mutation research.

[6]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Parker,et al.  Role of the fatty acid binding protein mal1 in obesity and insulin resistance. , 2003, Diabetes.

[8]  Shai Shaham,et al.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.

[9]  C. Alden.  Safety assessment for non-genotoxic rodent carcinogens: curves, low-dose extrapolations, and mecanisms in carcinogenesis , 2000, Human & experimental toxicology.

[10]  K. Tsai,et al.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage , 2002, Nature.

[11]  R. Maronpot,et al.  Molecular cloning and characterization of mouse CYP2J6, an unstable cytochrome P450 isoform. , 2002, Biochemical pharmacology.

[12]  R. Dunn,et al.  Concise review: gene expression applied to toxicology. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[14]  J. Barrett,et al.  Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells. , 1998, Mutagenesis.

[15]  M. Roth,et al.  Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity. , 1996, Cancer gene therapy.

[16]  R. Sitia,et al.  Changes in gene expression during the growth arrest of HepG2 hepatoma cells induced by reducing agents or TGFβ1 , 1998, Oncogene.

[17]  W. Caspary,et al.  Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: Results for 31 coded compounds in the national toxicology program , 1991, Environmental and molecular mutagenesis.

[18]  W. Paschen,et al.  Activation of MYD116 (gadd34) expression following transient forebrain ischemia of rat: implications for a role of disturbances of endoplasmic reticulum calcium homeostasis. , 1999, Brain research. Molecular brain research.

[19]  B H Margolin,et al.  Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. , 1987, Science.

[20]  R D Combes,et al.  The use of structure-activity relationships and markers of cell toxicity to detect non-genotoxic carcinogens. , 2000, Toxicology in vitro : an international journal published in association with BIBRA.

[21]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Devereux,et al.  Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years. , 2003, Toxicology and applied pharmacology.

[23]  Steven D. Cohen,et al.  Selective protein arylation and acetaminophen-induced hepatotoxicity. , 1997, Drug metabolism reviews.

[24]  M. Rajeevan,et al.  Copyright © American Society for Investigative Pathology and the Association for Molecular Pathology Validation of Array-Based Gene Expression Profiles by Real-Time (Kinetic) RT-PCR , 2022 .

[25]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[26]  Z. Ronai,et al.  Environmental factors as regulators and effectors of multistep carcinogenesis. , 1999, Carcinogenesis.

[27]  J. Rowley,et al.  LAPTM5: a novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells. , 1996, Genomics.

[28]  Robert R Young,et al.  Genetic toxicology: web resources. , 2002, Toxicology.

[29]  E. Thompson,et al.  Mutagenicity of alkyl glycidyl ethers in three short-term assays. , 1981, Mutation research.

[30]  R. Bodmer,et al.  Gtx: a novel murine homeobox‐containing gene, expressed specifically in glial cells of the brain and germ cells of testis, has a transcriptional repressor activity in vitro for a serum‐inducible promoter. , 1993, The EMBO journal.

[31]  O. MuellerS,et al.  ほ乳動物細胞における下剤成分エモジン,アロエ-エモジン及びダントロンの遺伝毒性 トポイソメラーゼIIの介在か , 1996 .

[32]  S. Taylor,et al.  D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T R Zacharewski,et al.  Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  D. Mcgregor,et al.  Responses of the L5178Y tk+/tk− mouse lymphoma cell forward mutation assay ii: 18 coded chemicals , 1988, Environmental and molecular mutagenesis.

[35]  R. Naz,et al.  Fertilization antigen-1: cDNA cloning, testis-specific expression, and immunocontraceptive effects. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  W. Pennie,et al.  Toxicogenomics; transcript profiling and potential application to chemical allergy. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[37]  S. Dudoit,et al.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.

[38]  H. Rosenkranz.  A data mining approach for the elucidation of the action of putative etiological agents: application to the non-genotoxic carcinogenicity of genistein. , 2003, Mutation research.

[39]  Errol Zeiger,et al.  Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: Confirmation of earlier results with 41 additional chemicals , 1990, Environmental and molecular mutagenesis.

[40]  Ravi Kothapalli,et al.  Microarray results: how accurate are they? , 2002, BMC Bioinformatics.

[41]  V. Fung,et al.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. , 1994, Science.